CoChat
Sign Up
Cited by 110

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal

Li, Yangchan, Xue, Meilin, Deng, Xiaolan, Dong, Lei, Nguyen, Le Xuan Truong, Ren, Lili, Han, Li, Li, Chenying, Xue, Jianhuang, Zhao, Zhicong, Li, Wei, Qing, Ying, Shen, Chao, Tan, Brandon, Chen, Zhenhua, Leung, Keith, Wang, Kitty, Swaminathan, Srividya, Li, Ling, Wunderlich, Mark, Mulloy, James C., Li, Xiaobo, Chen, Hao, Zhang, Bin, Horne, David, Rosen, Steven T., Marcucci, Guido, Xu, Mingjiang, Li, Zejuan, Wei, Minjie, Tian, Jingyan, Shen, Baiyong, Su, Rui, Chen, Jianjun·2023·Cell Stem Cell
DOI 10.1016/j.stem.2023.07.001
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2023.07.001

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 81

  1. Huang, 2013, TET1 plays an essential oncogenic role in MLL-rearranged leukemia, Proc. Natl. Acad. Sci. USA, 110, 11994, 10.1073/pnas.1310656110 · DOI
  2. Li, 2017, FTO plays an oncogenic role in acute myeloid leukemia as a N(6)-methyladenosine RNA demethylase, Cancer Cell, 31, 127, 10.1016/j.ccell.2016.11.017 · DOI
  3. Huang, 2020, RNA modifications in cancer: functions, mechanisms, and therapeutic implications, Annu. Rev. Cancer Biol., 4, 221, 10.1146/annurev-cancerbio-030419-033357 · DOI
  4. Shih, 2012, The role of mutations in epigenetic regulators in myeloid malignancies, Nat. Rev. Cancer, 12, 599, 10.1038/nrc3343 · DOI · Paper page
  5. Quivoron, 2011, TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis, Cancer Cell, 20, 25, 10.1016/j.ccr.2011.06.003 · DOI · Paper page
  6. Tefferi, 2009, TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis, Leukemia, 23, 905, 10.1038/leu.2009.47 · DOI
  7. He, 2011, Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA, Science, 333, 1303, 10.1126/science.1210944 · DOI
  8. Hu, 2013, Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation, Cell, 155, 1545, 10.1016/j.cell.2013.11.020 · DOI
  9. Weissmann, 2012, Landscape of TET2 mutations in acute myeloid leukemia, Leukemia, 26, 934, 10.1038/leu.2011.326 · DOI
  10. Chou, 2011, TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics, Blood, 118, 3803, 10.1182/blood-2011-02-339747 · DOI
  11. Abdel-Wahab, 2009, Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies, Blood, 114, 144, 10.1182/blood-2009-03-210039 · DOI · Paper page
  12. Itzykson, 2011, Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias, Leukemia, 25, 1147, 10.1038/leu.2011.71 · DOI
  13. Morinishi, 2020, Loss of TET2 affects proliferation and drug sensitivity through altered dynamics of cell-state transitions, Cell Syst., 11, 86, 10.1016/j.cels.2020.06.003 · DOI
  14. Shen, 2018, Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation, Nature, 554, 123, 10.1038/nature25434 · DOI · Paper page
  15. Guallar, 2018, RNA-dependent chromatin targeting of TET2 for endogenous retrovirus control in pluripotent stem cells, Nat. Genet., 50, 443, 10.1038/s41588-018-0060-9 · DOI · Paper page
  16. Fu, 2014, Tet-mediated formation of 5-hydroxymethylcytosine in RNA, J. Am. Chem. Soc., 136, 11582, 10.1021/ja505305z · DOI · Paper page
  17. Lan, 2020, Functional role of Tet-mediated RNA hydroxymethylcytosine in mouse ES cells and during differentiation, Nat. Commun., 11, 4956, 10.1038/s41467-020-18729-6 · DOI · Paper page
  18. Yang, 2017, 5-methylcytosine promotes mRNA export – NSUN2 as the methyltransferase and ALYREF as an m(5)C reader, Cell Res., 27, 606, 10.1038/cr.2017.55 · DOI · Paper page
  19. Yang, 2019, RNA 5-methylcytosine facilitates the maternal-to-zygotic transition by preventing maternal mRNA decay, Mol. Cell, 75, 1188, 10.1016/j.molcel.2019.06.033 · DOI
  20. Delatte, 2016, RNA biochemistry. Transcriptome-wide distribution and function of RNA hydroxymethylcytosine, Science, 351, 282, 10.1126/science.aac5253 · DOI · Paper page
  21. Kantarjian, 2021, Acute myeloid leukemia: current progress and future directions, Blood Cancer J., 11, 41, 10.1038/s41408-021-00425-3 · DOI
  22. Döhner, 2015, Acute myeloid leukemia, N. Engl. J. Med., 373, 1136, 10.1056/NEJMra1406184 · DOI
  23. Thol, 2020, Treatment of relapsed acute myeloid leukemia, Curr. Treat. Options Oncol., 21, 66, 10.1007/s11864-020-00765-5 · DOI
  24. Vetrie, 2020, The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML, Nat. Rev. Cancer, 20, 158, 10.1038/s41568-019-0230-9 · DOI
  25. Pollyea, 2017, Therapeutic targeting of acute myeloid leukemia stem cells, Blood, 129, 1627, 10.1182/blood-2016-10-696039 · DOI
  26. Thomas, 2017, Biology and relevance of human acute myeloid leukemia stem cells, Blood, 129, 1577, 10.1182/blood-2016-10-696054 · DOI
  27. Tasian, 2018, Targeting leukemia stem cells in the bone marrow niche, Biomedicines, 6, 10.3390/biomedicines6010022 · DOI
  28. Konopleva, 2011, Leukemia stem cells and microenvironment: biology and therapeutic targeting, J. Clin. Oncol., 29, 591, 10.1200/JCO.2010.31.0904 · DOI
  29. Zeng, 2009, Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML, Blood, 113, 6215, 10.1182/blood-2008-05-158311 · DOI
  30. Ko, 2010, Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2, Nature, 468, 839, 10.1038/nature09586 · DOI · Paper page
  31. Li, 2011, Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies, Blood, 118, 4509, 10.1182/blood-2010-12-325241 · DOI · Paper page
  32. Zhao, 2022, Opioid receptor signaling suppresses leukemia through both catalytic and non-catalytic functions of TET2, Cell Rep., 38, 110253, 10.1016/j.celrep.2021.110253 · DOI
  33. Hatlen, 2016, Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles, J. Exp. Med., 213, 25, 10.1084/jem.20150524 · DOI
  34. Bagger, 2019, BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles, Nucleic Acids Res., 47, D881, 10.1093/nar/gky1076 · DOI · Paper page
  35. Tyner, 2018, Functional genomic landscape of acute myeloid leukaemia, Nature, 562, 526, 10.1038/s41586-018-0623-z · DOI · Paper page
  36. Camp, 2004, X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization, Clin. Cancer Res., 10, 7252, 10.1158/1078-0432.CCR-04-0713 · DOI
  37. Boyerinas, 2013, Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy, Blood, 121, 4821, 10.1182/blood-2012-12-475483 · DOI
  38. Ko, 2011, Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice, Proc. Natl. Acad. Sci. USA, 108, 14566, 10.1073/pnas.1112317108 · DOI · Paper page
  39. Balise, 2020, Tetraspanin scaffold proteins function as key regulators of hematopoietic stem cells, Front. Cell Dev. Biol., 8, 598, 10.3389/fcell.2020.00598 · DOI
  40. Kwon, 2015, Tetraspanin 3 is required for the development and propagation of acute myelogenous leukemia, Cell Stem Cell, 17, 152, 10.1016/j.stem.2015.06.006 · DOI
  41. Marjon, 2016, Tetraspanin CD82 regulates bone marrow homing of acute myeloid leukemia by modulating the molecular organization of N-cadherin, Oncogene, 35, 4132, 10.1038/onc.2015.449 · DOI
  42. Saito-Reis, 2018, The tetraspanin CD82 regulates bone marrow homing and engraftment of hematopoietic stem and progenitor cells, Mol. Biol. Cell, 29, 2946, 10.1091/mbc.E18-05-0305 · DOI
  43. Mousavi, 2020, CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy, Immunol. Lett., 217, 91, 10.1016/j.imlet.2019.11.007 · DOI
  44. Cancilla, 2020, Targeting CXCR4 in AML and ALL, Front. Oncol., 10, 1672, 10.3389/fonc.2020.01672 · DOI
  45. Leung, 2011, The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells, Blood, 117, 1840, 10.1182/blood-2010-04-281329 · DOI
  46. Yoshida, 2011, CXCR4 expression on activated B cells is downregulated by CD63 and IL-21, J. Immunol., 186, 2800, 10.4049/jimmunol.1003401 · DOI
  47. Legrand, 2017, Statistically robust methylation calling for whole-transcriptome bisulfite sequencing reveals distinct methylation patterns for mouse RNAs, Genome Res., 27, 1589, 10.1101/gr.210666.116 · DOI
  48. Huang, 2019, Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia, Cancer Cell, 35, 677, 10.1016/j.ccell.2019.03.006 · DOI
  49. Qing, 2021, RNA modifications in hematopoietic malignancies: a new research frontier, Blood, 138, 637, 10.1182/blood.2019004263 · DOI
  50. Huang, 2020, m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer, Cancer Cell, 37, 270, 10.1016/j.ccell.2020.02.004 · DOI
  51. He, 2016, High-resolution mapping of RNA-binding regions in the nuclear proteome of embryonic stem cells, Mol. Cell, 64, 416, 10.1016/j.molcel.2016.09.034 · DOI
  52. He, 2021, TET2 chemically modifies tRNAs and regulates tRNA fragment levels, Nat. Struct. Mol. Biol., 28, 62, 10.1038/s41594-020-00526-w · DOI · Paper page
  53. Shen, 2021, TET-mediated 5-methylcytosine oxidation in tRNA promotes translation, J. Biol. Chem., 296, 100087, 10.1074/jbc.RA120.014226 · DOI
  54. Grozhik, 2019, Antibody cross-reactivity accounts for widespread appearance of m(1)A in 5′UTRs, Nat. Commun., 10, 5126, 10.1038/s41467-019-13146-w · DOI
  55. Zhang, 2019, Transcriptome-wide mapping of internal N(7)-methylguanosine methylome in mammalian mRNA, Mol. Cell, 74, 1304, 10.1016/j.molcel.2019.03.036 · DOI
  56. Ganzel, 2018, Very poor long-term survival in past and more recent studies for relapsed AML patients: the ECOG-ACRIN experience, Am. J. Hematol., 93, 1074, 10.1002/ajh.25162 · DOI
  57. Yates, 1973, Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia, Cancer Chemother. Rep., 57, 485
  58. Cucchi, 2020, Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: current techniques and implications for experimental design and outcome, Drug Resist. Updat., 53, 100730, 10.1016/j.drup.2020.100730 · DOI
  59. Agarwal, 2019, Mesenchymal niche-specific expression of CXCL12 controls quiescence of treatment-resistant leukemia stem cells, Cell Stem Cell, 24, 769, 10.1016/j.stem.2019.02.018 · DOI
  60. Nervi, 2009, Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100, Blood, 113, 6206, 10.1182/blood-2008-06-162123 · DOI
  61. Wang, 2014, Regulation of TET protein stability by calpains, Cell Rep., 6, 278, 10.1016/j.celrep.2013.12.031 · DOI
  62. Kazi, 2012, Suppressor of cytokine signaling 6 (SOCS6) negatively regulates Flt3 signal transduction through direct binding to phosphorylated tyrosines 591 and 919 of Flt3, J. Biol. Chem., 287, 36509, 10.1074/jbc.M112.376111 · DOI
  63. Campeau, 2009, A versatile viral system for expression and depletion of proteins in mammalian cells, PLoS One, 4, e6529, 10.1371/journal.pone.0006529 · DOI
  64. Stewart, 2003, Lentivirus-delivered stable gene silencing by RNAi in primary cells, RNA, 9, 493, 10.1261/rna.2192803 · DOI
  65. Naviaux, 1996, The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses, J. Virol., 70, 5701, 10.1128/jvi.70.8.5701-5705.1996 · DOI
  66. Li, 2011, RSEM: accurate transcript quantification from RNA-seq data with or without a reference genome, BMC Bioinformatics, 12, 323, 10.1186/1471-2105-12-323 · DOI · Paper page
  67. Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
  68. Thorvaldsdóttir, 2013, Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration, Brief. Bioinform., 14, 178, 10.1093/bib/bbs017 · DOI · Paper page
  69. He, 2017, Construction of a lentiviral vector containing shRNA targeting ADAM17 and its role in attenuating endotoxemia in mice, Mol. Med. Rep., 16, 6013, 10.3892/mmr.2017.7307 · DOI
  70. Su, 2022, METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis, Nat. Cell Biol., 24, 205, 10.1038/s41556-021-00835-2 · DOI
  71. Shen, 2020, RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia, Cell Stem Cell, 27, 64, 10.1016/j.stem.2020.04.009 · DOI
  72. Han, 2023, METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism, Cell Stem Cell, 30, 52, 10.1016/j.stem.2022.12.006 · DOI
  73. He, 2021, Bone marrow niche ATP levels determine leukemia-initiating cell activity via P2X7 in leukemic models, J. Clin. Invest., 131, 10.1172/JCI140242 · DOI
  74. Su, 2020, Targeting FTO suppresses cancer stem cell maintenance and immune evasion, Cancer Cell, 38, 79, 10.1016/j.ccell.2020.04.017 · DOI
  75. Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J. Immunol. Methods, 347, 70, 10.1016/j.jim.2009.06.008 · DOI
  76. Hao, 2019, Metabolic imaging reveals a unique preference of symmetric cell division and homing of leukemia-initiating cells in an endosteal niche, Cell Metab., 29, 950, 10.1016/j.cmet.2018.11.013 · DOI
  77. Zhang, 2021, Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML, J. Hematol. Oncol., 14, 122, 10.1186/s13045-021-01133-y · DOI
  78. Quinlivan, 2008, DNA digestion to deoxyribonucleoside: a simplified one-step procedure, Anal. Biochem., 373, 383, 10.1016/j.ab.2007.09.031 · DOI
  79. Martin, 2011, Cutadapt removes adapter sequences from high-throughput sequencing reads, EMBnet. J., 17, 10, 10.14806/ej.17.1.200 · DOI · Paper page
  80. Rieder, 2016, meRanTK: methylated RNA analysis ToolKit, Bioinformatics, 32, 782, 10.1093/bioinformatics/btv647 · DOI
  81. Chen, 2019, 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs, Nat. Cell Biol., 21, 978, 10.1038/s41556-019-0361-y · DOI

Cited by

Metadata

Authors
Li, Y., Xue, M., Deng, X., Dong, L., Nguyen, L. X. T., Ren, L., Han, L., Li, C., Xue, J., Zhao, Z., Li, W., Qing, Y., Shen, C., Tan, B., Chen, Z., Leung, K., Wang, K., Swaminathan, S., Li, L., Wunderlich, M., Mulloy, J. C., Li, X., Chen, H., Zhang, B., Horne, D., Rosen, S. T., Marcucci, G., Xu, M., Li, Z., Wei, M., Tian, J., Shen, B., Su, R., & Chen, J.
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2023-08
Volume
30
Issue
8
Pages
1072-1090.e10
ISSN
1934-5909
DOI
10.1016/j.stem.2023.07.001
Cited by
110
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review